Author:
Tsay Sharon,Welsh Rory M.,Adams Eleanor H.,Chow Nancy A.,Gade Lalitha,Berkow Elizabeth L.,Poirot Eugenie,Lutterloh Emily,Quinn Monica,Chaturvedi Sudha,Kerins Janna,Black Stephanie R.,Kemble Sarah K.,Barrett Patricia M.,Barton Kerri,Shannon D.J.,Bradley Kristy,Lockhart Shawn R.,Litvintseva Anastasia P.,Moulton-Meissner Heather,Shugart Alicia,Kallen Alex,Vallabhaneni Snigdha,Chiller Tom M.,Jackson Brendan R.,
Publisher
Centers for Disease Control MMWR Office
Subject
Health Information Management,Health, Toxicology and Mutagenesis,General Medicine,Health (social science),Epidemiology
Reference4 articles.
1. Investigation of the first seven reported cases of Candida auris, a globally emerging invasive, multidrug-resistant fungus—United States, May 2013–August 2016.;Vallabhaneni;MMWR Morb Mortal Wkly Rep,2016
2. Simultaneous emergence of multidrug-resistant Candida auris on 3 continents confirmed by whole-genome sequencing and epidemiological analyses.;Lockhart;Clin Infect Dis,2017
3. CDC. Candida auris interim recommendations for healthcare facilities and laboratories. Atlanta, GA: US Department of Health and Human Services, CDC; 2017. https://www.cdc.gov/fungal/diseases/candidiasis/recommendations.html#infection
4. Environmental Protection Agency. Pesticide registration. List K: EPA’s registered antimicrobial products effective against Clostridium difficile spores. Washington, DC: Environmental Protection Agency; 2017. https://www.epa.gov/pesticide-registration/list-k-epas-registered-antimicrobial-products-effective-against-clostridium
Cited by
131 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献